NewsRx

Search our medical news database

Oncology Business Week

Susan Hasty, Publisher

Table of Contents . . . October 24th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Oncology Business Week | Other Publications

Amgen, Inc. - Aranesp approved for extended dosing by European Commission

Aphton Corporation - Therapeutic antibody deal signed to develop gastrointestinal cancer therapies

Australian Cancer Technology - Australian oncology firm lists on Frankfurt exchange

Cancer Screening - Preventive healthcare can overcome barriers of race, socioeconomic status

CancerVax Corporation - Enrollment completed in phase III trial of Canvaxin

Cerus Corporation - Efficacy and safety for cancer immunotherapy preclinical results published

Collaborations - Merck partnering with Nastech on nasal spray obesity drug

Curis, Inc. - Compound eradicates brain tumor in preclinical cancer model

Favrille, Inc. - Company initiates phase III clinical trial for FavId

Genentech, Inc. - Study of drug for advanced pancreatic cancer shows significant survival benefit

Genetronics Biomedical Corp. - Walter Singleton named vice president, clinical and regulatory affairs

Imaging Diagnostic Systems, Inc. - Agreement signed for exclusive sale of CT Laser Mammography System in China

Immunicon Corp. - Blood test provides window into treatment of metastatic cancer

Immunomedics, Inc. - Biopharmaceutical company's therapeutics candidates highlighted at conference

Medarex, Inc. - Combination trial to study MDX-010 with GVAX prostate cancer vaccine

Power3 Medical Products, Inc. - Research agreement signed to ID early biomarkers for breast cancer

Adherex Technologies, Inc. - Oncology company files registration statement with SEC

Alchemia Limited - Positive results reported for Alchemia anticancer compound

American Cancer Society - Survey finds one in three Connecticut adults experience pain on a daily basis

Baptist Medical Center - Diffuse malignant mesothelioma of the peritoneum and pleura studied

Baxa Corporation - Occupational safety institute published hazardous drug exposure report

Baylor College of Medicine, Houston - EBNA1-specific CD4+ T cells are key for control of Burkitt lymphoma

BioSphere Medical, Inc. - Device company appoints Martin Joyce as chief financial officer

Bispebjerg Hospital, Copenhagen - Study validates Sexual function-Vaginal changes Questionnaire

Cancer - Wellness/image booklet helps women undergoing, recovering from cancer therapy

Cancer Prevention - Actress urges adding cancer screening to women's healthcare

Cancer Treatment - Genetic test signals who will benefit from brain cancer drug

Charite University of Med Center Berlin - Pamidronate, zoledronate inhibit proliferation of human melanoma cells

Charles Nicolle Hosp., Rouen - IUD often a concomitant factor in tumoral syndrome due to bacterial infection

Chiba Cancer Center - Midkine promoter-driven gene therapy strikes down immortalized and tumor cells

Clavis Pharma AS - Anti-cancer drug CP-4055 shows promise of efficacy in phase I clinical study

Clinical Trials - Registry push could ease patients' hunt for drug

Complutense University, Madrid - Cannabinoids have several means for controlling glioma growth

Cytogen Corporation - Data demonstrates potential role for QUADRAMET in acute myeloid leukemia

DakoCytomation - Cancer diagnostics company launches automated staining instrument

Dartmouth Medical School - New arsenic drinking water standard may still be toxic

Erasmus Medical Center, in Rotterdam - Lycopene slows human prostate tumor growth in mice

Fourth Military Medical Univ., Shaanxi Province - Heat shock protein tumor vaccine enhances immune responses

Fourth Military Medical Univ., Xian - Nanoparticle-containing adriamycin increases distribution of the drug

Fox Chase Cancer Center - NHEJ DNA repair pathway has role in completion of HIV-1 DNA integration process

Fred Hutchinson Cancer Res. Ctr. - A glass of red wine a day may keep prostate cancer away

Gender-Based Medicine - Men, women more different than thought

Hadassah University Hospital - Transfected liver cancer cells offer a new venue for exploring hepatitis B

Hepatitis B - WHO stresses importance of childhood immunization against hepatitis B

Hormone Replacement Therapy - ACOG issues state-of-the-art guide to HRT

Hormone Replacement Therapy - Short-term impairment of gallbladder emptying associated with HRT

Human Genome Sciences, Inc. - HGS-ETR2 trials demonstrate safety, tolerability in advanced cancer patients

IDM - U.S. FDA authorizes start of phase 2 clinical trial on melanoma vaccine

IFR Jean Roche - VEGF signals the probability of breast cancer progression

ILEX Oncology, Inc. - FDA Oncologic Drugs Advisory Committee to review clofarabine

Indiana University - Interferon-gamma infusion prepares recipients for genetically modified cells

Inex Pharmaceuticals Corporation - Marqibo to be reviewed by FDA Oncologic Drugs Advisory Committee

Institute for Cancer Research & Treatment, Italy - Leukemia-derived dendritic cells become cells that stimulate T cells

Isis Pharmaceuticals - Antisense drug targeting STAT-3 demonstrates significant antitumor activity

Istanbul University - Turkish version of the CHBMS found adequately reliable, valid in Turkish women

Italian Soc. of Med. Radiology - MR is better than mammography for detecting additional disease in patients

Karolinska Institute - DNA vaccine elicits immune response in patients with prostate cancer

Kurume University, Fukuoka - Peptides eliciting multiple responses in lung cancer identified

Laval University - Dehydroepiandrosterone effect on heart disease risk is modest

Lilly - Alimta approved in the European Union for two cancer indications

London Research Institute - Cancer scientists make unexpected discovery on sperm development

Lorus Therapeutics Inc. - Virulizin study results published

Louisiana State University - Curing Helicobacter pylori infection does not prevent all gastric cancers

Lund University - Neural progenitor cell lines inhibit tumor growth

M.D. Anderson Cancer Center - Infliximab well tolerated/effective for steroid-resistant acute GVHD treatment

M.D. Anderson Cancer Center - Molecular switch found that allows cancer cells to become mobile

MEDTEC - Companies partner to distribute OneDose patient dosimetry system

MGI Pharma, Inc. - Kadian marketed in U.S. for cancer-associated pain

Matritech, Inc. - NMP66 breast cancer detection results presented at conference

Maxim Pharmaceuticals - Ceplene trial in advanced malignant melanoma fails to meet primary endpoint

National Cheng Kung University Medical College - The cytostatic effect of TNP-470 involves cyclin D1

National University of Singapore Hospital - Telomerase activity and COX-2 may be potential markers for certain cancers

Norwegian Cancer Society - Researchers report on professional collaboration with cancer patients, families

OSI Pharmaceuticals - Trials for tumor-blocking pancreatic cancer drug plus chemotherapy promising

Ovarian Cancer - Gene amplification is one mechanism for hK6 overexpression in ovarian cancer

Peregrine Pharmaceuticals, Inc. - Pharmaceutical company submits IND for novel anticancer agent Tarvacin

Pharmacyclics, Inc. - Pharma company releases data from phase 1 for nonHodgkin's B-cell lymphomas

PhotoCure - Swedish regulatory authorities to approve novel imaging drug Hexvix

PowderMed Ltd - Clinical trial initiated for novel therapeutic DNA cancer vaccine

Protherics PLC - Biopharma company names U.S. VP sales and marketing, provides business update

Proxima Therapeutics, Inc. - Medical device company received FDA clearance for MammoSite balloon catheter

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook